Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AAV-TT
Therapeutic Area : Genetic Disease
Study Phase : Preclinical
Sponsor : Cure Sanfilippo Foundation
Deal Size : $0.4 million
Deal Type : Funding
Cure Sanfilippo Grants $380,000 to Type C Gene Therapy Development
Details : The funding will help support creation of plasmid (a critical component of gene therapy drug production), as well as the required in-vivo efficacy study in the MPS IIIC mouse model.
Product Name : AAV-TT
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
May 15, 2020
Lead Product(s) : AAV-TT
Therapeutic Area : Genetic Disease
Highest Development Status : Preclinical
Sponsor : Cure Sanfilippo Foundation
Deal Size : $0.4 million
Deal Type : Funding